- Home
- LTBR vs HUMA Comparison
LTBR vs HUMA Comparison
Compare LTBR & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTBR | HUMA |
|---|---|---|
| Founded | 1992 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.7M | 165.7M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LTBR | HUMA |
|---|---|---|
| Price | $5.08 | $0.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.63 |
| AVG Volume (30 Days) | 640.8K | ★ 5.8M |
| Earning Date | 11-02-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.37 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,038,000.00 |
| Revenue This Year | N/A | $72.32 |
| Revenue Next Year | N/A | $518.79 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.87 | $0.34 |
| 52 Week High | $28.44 | $1.78 |
Technical Indicators
Market Signals| Indicator | LTBR | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 33.45 | 36.62 |
| Support Level | $4.87 | $0.34 |
| Resistance Level | $7.04 | $0.75 |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 8.75 | 39.45 |
Price Performance
Historical ComparisonAbout LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, engaged in research and development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.